Today: 5 April 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Guardant Health stock jumps 7% as Evercore downgrades — what investors watch next

Guardant Health stock jumps 7% as Evercore downgrades — what investors watch next

Guardant Health shares jumped 7.2% to $109.24 Tuesday, nearing their 52-week high, despite Evercore ISI downgrading the stock while raising its price target to $105. A Form 4 filing showed Chief People Officer Terilyn J. Monroe received 17,555 shares through vested stock units. Shares have climbed about 200% in the past year. Investors are watching Medicare reimbursement rates for Guardant’s Shield blood test.
6 January 2026
Hecla Mining stock jumps 12% as silver tops $80 and Investor Day nears

Hecla Mining stock jumps 12% as silver tops $80 and Investor Day nears

Hecla Mining shares surged 11.6% to $22.02 in afternoon trading Tuesday, tracking a 5.3% jump in spot silver to $80.57 an ounce. The move follows Hecla’s announcement of an Investor Day and NYSE closing bell event on January 26. Other U.S.-listed silver miners rose but lagged Hecla’s gains. Investors await Friday’s U.S. payrolls report for further direction.
Regencell Bioscience (RGC) stock jumps again: what to know behind the latest sharp swing

Regencell Bioscience (RGC) stock jumps again: what to know behind the latest sharp swing

Regencell Bioscience Holdings shares jumped 18.3% to $31.99 in midday Nasdaq trading Tuesday, after swinging between $26.60 and $34.40. No new company statements have been posted since its Oct. 31 annual report, which disclosed a DOJ trading probe and “substantial doubt” about its ability to continue as a going concern. About 850,000 shares changed hands.
Beam Therapeutics stock rises 5% after BofA lifts target to $45

Beam Therapeutics stock rises 5% after BofA lifts target to $45

Beam Therapeutics shares rose about 5% to $28.24 by early afternoon Tuesday after Bank of America raised its price target to $45 and reaffirmed a buy rating. The stock touched $30.49 before paring gains. A new SEC filing showed Chief Legal Officer Christine Bellon sold 1,254 shares on Dec. 31 in an automatic transaction tied to tax withholding.
6 January 2026
Microchip Technology stock jumps 10% after MCHP boosts Q3 sales outlook

Microchip Technology stock jumps 10% after MCHP boosts Q3 sales outlook

Microchip Technology shares jumped 10.2% to $73.93 after the company raised its fiscal Q3 net sales outlook to about $1.185 billion, above its prior forecast. CEO Steve Sanghi cited strong bookings and a higher March-quarter backlog. The company will release full results Feb. 5 and filed an 8-K update with regulators. Several analysts raised price targets following the announcement.
Warby Parker stock jumps 9% as TD Cowen lifts target — what investors watch next

Warby Parker stock jumps 9% as TD Cowen lifts target — what investors watch next

Warby Parker shares jumped 9.3% to $25.42 in midday trading Tuesday after touching $25.93, following TD Cowen’s price target hike to $26. Volume topped 2.6 million shares. Loop Capital named the stock a top pick for 2026. Traders weighed analyst optimism against risks ahead of the company’s next earnings, expected in late February.
Fermi Inc (FRMI) stock jumps nearly 10% as class-action filing adds pressure

Fermi Inc (FRMI) stock jumps nearly 10% as class-action filing adds pressure

Fermi shares jumped 9.8% to $9.53 midday Tuesday after a securities-fraud class action was filed in New York, alleging the company overstated tenant demand for its Texas campus. The suit follows a December disclosure that a key tenant terminated a $150 million commitment, which sent shares down 33.8%. Investors have until March 6 to seek lead-plaintiff status. Fermi stock remains well below its $21 IPO price.
6 January 2026
Sandisk stock surges 23% as Nvidia CES update puts AI data-center storage back in play

Sandisk stock surges 23% as Nvidia CES update puts AI data-center storage back in play

Sandisk shares surged 23.4% to $338.26 in midday trading Tuesday, leading gains in storage and memory stocks after the company unveiled its new “Optimus” SSD brand at CES. Nvidia highlighted rising AI demand for context memory, announcing its Inference Context Memory Storage Platform and next-generation Vera Rubin system. Micron, Western Digital, and Seagate also posted strong advances.
Wave Life Sciences stock jumps 17% as obesity gene-silencing race heats up

Wave Life Sciences stock jumps 17% as obesity gene-silencing race heats up

Wave Life Sciences shares surged 17.2% to $17.58 Tuesday on heavy volume, after new data from Arrowhead Pharmaceuticals showed weight loss benefits from RNAi obesity drugs. Wave is developing a similar therapy, WVE-007, targeting the same gene. The company recently raised $402.5 million in a public offering. Investors await further trial results expected in early 2026.
Sandisk stock jumps 22% today as CES Optimus SSD rebrand and rising NAND price forecasts lift SNDK

Sandisk stock jumps 22% today as CES Optimus SSD rebrand and rising NAND price forecasts lift SNDK

Sandisk shares surged over 22% Tuesday, hitting a 52-week high of $343 after the company unveiled its “Sandisk Optimus” SSD branding at CES 2026. About 12.9 million shares changed hands by 11:05 a.m. ET. TrendForce expects NAND flash contract prices to rise up to 38% in the first quarter. Sandisk completed its split from Western Digital in February 2025.
6 January 2026
1 292 293 294 295 296 584

Stock Market Today

  • Freshpet (FRPT) Stock Slides 28% in One Month but DCF Model Signals Undervaluation
    April 5, 2026, 10:00 AM EDT. Freshpet's share price plunged 28.1% over the past month to close at $59.40 amid ongoing volatility. Despite this, a Discounted Cash Flow (DCF) analysis reveals the stock is trading at a 36% discount to its intrinsic value of $92.94 per share, suggesting undervaluation. The DCF method estimates a company's worth by projecting future cash flows and discounting them to today's value. Freshpet, a pet food company in the U.S. Food, Beverage & Tobacco sector, faces a one-year return decline of 25.3%, lagging behind peers. Its niche in consumer staples and ongoing interest in pet spending maintain investor focus. Freshpet's valuation score stands at 3 out of 6, reflecting mixed signals between growth potential and financial risks.
Go toTop